Evidence map›Paper›PMID 35334570›Full record

Trial reportMedicina (Kaunas, Lithuania)2022

Ameliorative Potential of L-Alanyl L-Glutamine Dipeptide in Colon Cancer Patients Receiving Modified FOLFOX-6 Regarding the Incidence of Diarrhea, the Treatment Response, and Patients' Survival: A Randomized Controlled Trial.

Nesreen M Sabry, Tamer M Naguib, Ahmed M Kabel, El-Sayed Khafagy, Hany H Arab, Walid A Almorsy

Open access · goldAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Medicina (Kaunas, Lithuania), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Nesreen M SabryClinical Oncology Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.ORCID 0000-0001-5458-3422
Tamer M NaguibAnesthesia and ICU Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
Ahmed M KabelDepartment of Pharmacology, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.ORCID 0000-0002-5101-8011
El-Sayed KhafagyDepartment of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-Kharj 11942, Saudi Arabia.ORCID 0000-0002-3741-0893
Hany H ArabDepartment of Pharmacology and Toxicology, College of Pharmacy, Taif University, P.O. Box 11099, Taif 21944, Saudi Arabia.
Walid A AlmorsyClinical Oncology Department, Faculty of Medicine, Tanta University, Tanta 31527, Egypt.
Tanta University · EGSuez Canal University · EGTaif University · SA

Funding

Taif University TURSP-2020/29
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Colonic NeoplasmsGlutamineAntineoplastic Combined Chemotherapy ProtocolsDiarrheaDipeptidesFluorouracilHumansIncidenceLeucovorinOrganoplatinum CompoundsQuality of LifeDipeptidesFluorouracilGlutamineLeucovorinOrganoplatinum Compoundscolon cancerdiarrheaFOLFOXL-alanyl L-glutamine dipeptidepatients’ survival

Identifiers

PMID35334570
PMCPMC8955640
OpenAlexW4220850349

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.